These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31744004)

  • 1. Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    Defrancesco M; Marksteiner J; Kemmler G; Dal-Bianco P; Ransmayr G; Benke T; Mosbacher J; Höller Y; Schmidt R
    J Alzheimers Dis; 2020; 73(1):125-133. PubMed ID: 31744004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM).
    Pirker-Kees A; Dal-Bianco P; Schmidt R
    J Alzheimers Dis; 2019; 71(2):623-630. PubMed ID: 31424389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study.
    Canevelli M; Adali N; Cantet C; Andrieu S; Bruno G; Cesari M; Vellas B;
    J Neurol; 2013 Jul; 260(7):1859-65. PubMed ID: 23504051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and psychological subsyndromes in Alzheimer's disease using the Neuropsychiatric Inventory.
    Canevelli M; Adali N; Voisin T; Soto ME; Bruno G; Cesari M; Vellas B
    Int J Geriatr Psychiatry; 2013 Aug; 28(8):795-803. PubMed ID: 23147419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum NfL in Alzheimer Dementia: Results of the Prospective Dementia Registry Austria.
    Kern D; Khalil M; Pirpamer L; Buchmann A; Hofer E; Dal-Bianco P; Stögmann E; Scherfler C; Benke T; Ransmayr G; Schmidt R
    Medicina (Kaunas); 2022 Mar; 58(3):. PubMed ID: 35334608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driving cessation and dementia: results of the prospective registry on dementia in Austria (PRODEM).
    Seiler S; Schmidt H; Lechner A; Benke T; Sanin G; Ransmayr G; Lehner R; Dal-Bianco P; Santer P; Linortner P; Eggers C; Haider B; Uranues M; Marksteiner J; Leblhuber F; Kapeller P; Bancher C; Schmidt R;
    PLoS One; 2012; 7(12):e52710. PubMed ID: 23300746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric symptoms and subsyndromes in patients with different stages of dementia in primary care follow-up (NeDEM project): a cross-sectional study.
    García-Martín V; de Hoyos-Alonso MC; Ariza-Cardiel G; Delgado-Puebla R; García-Domingo P; Hernández-Melo E; de Haro-de Torres JL; Del Cura-González I
    BMC Geriatr; 2022 Jan; 22(1):71. PubMed ID: 35065615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Category verbal fluency predicted changes in behavioral and psychological symptoms of dementia in patients with Alzheimer's disease.
    Tsai CF; Wang SJ; Zheng L; Fuh JL
    Psychiatry Clin Neurosci; 2010 Aug; 64(4):408-14. PubMed ID: 20573053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of patient dependence in mild-to-moderate Alzheimer's disease.
    Benke T; Sanin G; Lechner A; Dal-Bianco P; Ransmayr G; Uranüs M; Marksteiner J; Gaudig M; Schmidt R;
    J Alzheimers Dis; 2015; 43(2):443-9. PubMed ID: 25096619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease.
    Ng KP; Pascoal TA; Mathotaarachchi S; Chan YH; Jiang L; Therriault J; Benedet AL; Shin M; Kandiah N; Greenwood CMT; Rosa-Neto P; Gauthier S;
    Transl Neurodegener; 2021 Jan; 10(1):1. PubMed ID: 33390174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.
    Vik-Mo AO; Giil LM; Ballard C; Aarsland D
    Int J Geriatr Psychiatry; 2018 Oct; 33(10):1361-1369. PubMed ID: 29979473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.
    Nagata T; Shinagawa S; Nakajima S; Mimura M; Shigeta M
    J Alzheimers Dis; 2018; 66(1):139-148. PubMed ID: 30248052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, and its relationship with cognitive impairment.
    M FM; Molano A; Castro J; Zarranz JJ
    Curr Alzheimer Res; 2010 Sep; 7(6):517-26. PubMed ID: 20455862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-Specific Differences in Cognitive Profiles of Patients with Alzheimer's Disease: Results of the Prospective Dementia Registry Austria (PRODEM-Austria).
    Pusswald G; Lehrner J; Hagmann M; Dal-Bianco P; Benke T; Marksteiner J; Mosbacher J; Ransmayr G; Sanin G; Schmidt R
    J Alzheimers Dis; 2015; 46(3):631-7. PubMed ID: 25835423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of Life in relation to neuropsychiatric symptoms in Alzheimer's disease: 5-year prospective ALSOVA cohort study.
    Hongisto K; Hallikainen I; Selander T; Törmälehto S; Väätäinen S; Martikainen J; Välimäki T; Hartikainen S; Suhonen J; Koivisto AM
    Int J Geriatr Psychiatry; 2018 Jan; 33(1):47-57. PubMed ID: 28067961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric symptoms in Alzheimer's disease: associations with caregiver burden and treatment outcomes.
    Chen CT; Chang CC; Chang WN; Tsai NW; Huang CC; Chang YT; Wang HC; Kung CT; Su YJ; Lin WC; Cheng BC; Su CM; Hsiao SY; Hsu CW; Lu CH
    QJM; 2017 Sep; 110(9):565-570. PubMed ID: 28383687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
    Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
    Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognition, gender, and functional abilities in Alzheimer's disease: how are they related?
    Benke T; Delazer M; Sanin G; Schmidt H; Seiler S; Ransmayr G; Dal-Bianco P; Uranüs M; Marksteiner J; Leblhuber F; Kapeller P; Bancher C; Schmidt R
    J Alzheimers Dis; 2013; 35(2):247-52. PubMed ID: 23388173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.